Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

The cancer-immunity cycle: Indication, genotype, and immunotype
Ira Mellman, Daniel S. Chen, Thomas Powles, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2188-2205
Open Access | Times Cited: 345
Electrospun fiber‐based immune engineering in regenerative medicine
Yiru Xu, Qimanguli Saiding, Xue Zhou, et al.
Smart Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 61
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 60
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 40
Stimulus‐Responsive Copper Complex Nanoparticles Induce Cuproptosis for Augmented Cancer Immunotherapy
Fuzhen Hu, Jia Huang, Tiejun Bing, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 37
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Nutrients: Signal 4 in T cell immunity
Jana Raynor, Hongbo Chi
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 3
Open Access | Times Cited: 26
Regulation and impact of tumor-specific CD4+ T cells in cancer and immunotherapy
Mengdi Guo, M. Liu, David G. Brooks
Trends in Immunology (2024) Vol. 45, Iss. 4, pp. 303-313
Closed Access | Times Cited: 20
Histone lactylation drives CD8+ T cell metabolism and function
Deblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, et al.
Nature Immunology (2024) Vol. 25, Iss. 11, pp. 2140-2151
Closed Access | Times Cited: 20
CD8+ T cell-based cancer immunotherapy
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Immunometabolism of CD8+ T cell differentiation in cancer
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 15
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Zachary Sethna, Pablo Guasp, Charlotte Reiche, et al.
Nature (2025)
Open Access | Times Cited: 6
KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection
Eric Fagerberg, John Attanasio, Christine Dien, et al.
Science (2025) Vol. 387, Iss. 6735
Closed Access | Times Cited: 2
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
Shouyan Deng, Yibo Zhang, Huanbin Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2305-2323.e33
Closed Access | Times Cited: 15
Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
Michael T. Lotze, Scott H. Olejniczak, Dimitris Skokos
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 878-895
Closed Access | Times Cited: 12
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
Resident memory T cells and cancer
Noah Veis Gavil, Katarina Cheng, David Masopust
Immunity (2024) Vol. 57, Iss. 8, pp. 1734-1751
Closed Access | Times Cited: 9
Next-generation combination approaches for immune checkpoint therapy
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 8
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Self-Cascaded Pyroptosis-STING Initiators for Catalytic Metalloimmunotherapy
Qiao Yu, Shumin Sun, Nailin Yang, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Functional nanoplatform for modulating cellular forces to enhance antitumor immunity via mechanotransduction
Wanheng Zhang, Shuqin Liu, Yan Hou, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 850-865
Closed Access | Times Cited: 1
Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective
Yang Xiao, Yongsheng Li, Huakan Zhao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top